High-dose inhaled corticosteroid use in childhood asthma: an observational study of GP prescribing.
- 1 October 2006
- journal article
- Vol. 56 (531), 788-90
Abstract
Inhaled corticosteroids are effective and safe treatments for childhood asthma in standard doses, yet at high dosages they may be associated with adverse events and suboptimal outcomes; add-on therapy is, therefore, recommended to minimise their use. We quantified prescribing of high-dose inhaled corticosteroids and add-on therapy in children in July 2003 and found that high-dose inhaled corticosteroids were prescribed to 10% of children aged 5-11 years and 6% of under-5's who were treated for asthma. Add-on therapy was lacking for almost half of these individuals. Some children were receiving treatment not in accord with current licences and evidence-based recommendations and, as such, may be at risk of adverse outcomes.Keywords
This publication has 6 references indexed in Scilit:
- Developing a large electronic primary care database (Doctors’ Independent Network) for researchInternational Journal of Medical Informatics, 2004
- Chapters 1-3Thorax, 2003
- Survey of adrenal crisis associated with inhaled corticosteroids in the United KingdomArchives of Disease in Childhood, 2002
- Lesson of the week: Symptomatic adrenal insufficiency presenting with hypoglycaemia in children with asthma receiving high dose inhaled fluticasone propionate * Commentary: Exogenous glucocorticoids influence adrenal function, but assessment can be difficultBMJ, 2002
- Addition of Salmeterol versus Doubling the Dose of Beclomethasone in Children with AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 1998
- A comparison of the efficacy and safety of inhaled corticosteroids in asthmaAllergy, 1997